Ryan David Nipp

8.8k total citations · 2 hit papers
243 papers, 4.5k citations indexed

About

Ryan David Nipp is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Economics and Econometrics. According to data from OpenAlex, Ryan David Nipp has authored 243 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 139 papers in Oncology, 97 papers in Public Health, Environmental and Occupational Health and 61 papers in Economics and Econometrics. Recurrent topics in Ryan David Nipp's work include Palliative Care and End-of-Life Issues (80 papers), Cancer survivorship and care (78 papers) and Childhood Cancer Survivors' Quality of Life (48 papers). Ryan David Nipp is often cited by papers focused on Palliative Care and End-of-Life Issues (80 papers), Cancer survivorship and care (78 papers) and Childhood Cancer Survivors' Quality of Life (48 papers). Ryan David Nipp collaborates with scholars based in United States, Canada and Germany. Ryan David Nipp's co-authors include Jennifer S. Temel, Areej El‐Jawahri, Vicki A. Jackson, Joseph A. Greer, William F. Pirl, Elyse R. Park, Emily R. Gallagher, David P. Ryan, Lara Traeger and Joseph A. Greer and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Ryan David Nipp

209 papers receiving 4.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Palliative Care for Patients With Cancer: ASCO Guideline Update

2024 75 citations Ryan David Nipp, Betty Ferrell et al. Journal of Clinical Oncology profile →
The crosstalk between macrophages and cancer cells potentiates pancreatic cancer cachexia

2024 60 citations Ryan David Nipp et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ryan David Nipp United States	37	2.3k	1.8k	927	664	658	243	4.5k
Antonia V. Bennett United States	28	2.6k 1.1×	1.2k 0.7×	824 0.9×	826 1.2×	571 0.9×	121	4.5k
Fabio Efficace Italy	46	3.1k 1.3×	1.3k 0.7×	1.0k 1.1×	1.5k 2.2×	974 1.5×	215	6.6k
Eric Linn United States	3	3.0k 1.3×	994 0.6×	1.3k 1.4×	1.1k 1.6×	430 0.7×	6	4.8k
Gregory A. Abel United States	36	1.7k 0.7×	1.3k 0.7×	809 0.9×	470 0.7×	599 0.9×	221	4.8k
F. Lennie Wong United States	32	1.4k 0.6×	1.5k 0.8×	1.8k 1.9×	624 0.9×	324 0.5×	140	4.8k
Arif H. Kamal United States	38	1.3k 0.5×	2.7k 1.5×	1.2k 1.3×	337 0.5×	401 0.6×	237	4.9k
Kathryn E. Weaver United States	36	2.0k 0.9×	942 0.5×	860 0.9×	640 1.0×	748 1.1×	141	4.4k
Lisa Barbera Canada	37	2.6k 1.1×	2.9k 1.6×	1.6k 1.7×	808 1.2×	456 0.7×	210	5.9k
Juan Ignacio Arrarás Spain	29	2.7k 1.2×	913 0.5×	668 0.7×	1.3k 2.0×	324 0.5×	95	4.9k
M. Groenvold Denmark	22	3.4k 1.4×	841 0.5×	982 1.1×	1.3k 2.0×	497 0.8×	41	5.4k

Countries citing papers authored by Ryan David Nipp

Since Specialization

Citations

This map shows the geographic impact of Ryan David Nipp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan David Nipp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan David Nipp more than expected).

Fields of papers citing papers by Ryan David Nipp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryan David Nipp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan David Nipp. The network helps show where Ryan David Nipp may publish in the future.

Co-authorship network of co-authors of Ryan David Nipp

This figure shows the co-authorship network connecting the top 25 collaborators of Ryan David Nipp. A scholar is included among the top collaborators of Ryan David Nipp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryan David Nipp. Ryan David Nipp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bergerot, Cristiane Decat, Paulo Gustavo Bergerot, Da Silva, et al.. (2025). The impact of a geriatric assessment‐guided management intervention (GAIN‐S) on prognostic awareness: A randomized controlled trial. Cancer. 131(17). e70054–e70054.

Sørensen, Leif, et al.. (2025). Perioperative Supportive Care Interventions to Enhance Surgical Outcomes for Older Adults With Cancer: A Systematic Review. JCO Oncology Practice. 21(8). 1106–1117.

Nipp, Ryan David, et al.. (2025). Management of Advanced Hepatocellular Carcinoma: A Review and Practical Guide. JCO Oncology Practice. 21(9). 1247–1256.

Chino, Fumiko & Ryan David Nipp. (2025). Financial Toxicity in Cancer Care: Where Are We, and How Did We Get Here? Introduction to a Special Series. JCO Oncology Practice. 21(1). 1–3. 2 indexed citations

Durbin, Sienna, Andrea Pelletier, Laura A. Petrillo, et al.. (2024). Change in financial toxicity during early-phase cancer clinical trial (EP-CT) participation.. Journal of Clinical Oncology. 42(16_suppl). 11119–11119. 1 indexed citations

Pelletier, Andrea, Sienna Durbin, Laura A. Petrillo, et al.. (2024). Associations of symptom burden with patient-reported outcomes (PROs) and clinical outcomes among early-phase cancer clinical trial (EP-CT) participants.. Journal of Clinical Oncology. 42(16_suppl). 11101–11101.

Bergerot, Cristiane Decat, Paulo Gustavo Bergerot, Carlos Gil Ferreira, et al.. (2024). Quality of life for older patients with metastatic cancer in Brazil: A telehealth-based geriatric assessment and supportive care intervention (GAIN-S).. Journal of Clinical Oncology. 42(16_suppl). 1514–1514. 1 indexed citations

Dhawale, Tejaswini, R. Bhat, P. Connor Johnson, et al.. (2024). Telemedicine-based serious illness conversations, healthcare utilization, and end of life care among patients with advanced lung cancer. The Oncologist. 29(12). e1762–e1769. 1 indexed citations

Karzai, Fatima, et al.. (2024). Increasing diversity in clinical trials: demographic trends at the National Cancer Institute, 2005-2020. JNCI Journal of the National Cancer Institute. 116(7). 1063–1071. 5 indexed citations

10.

Durbin, Sienna, Andrea Pelletier, Laura A. Petrillo, et al.. (2024). Financial toxicity in early‐phase cancer clinical trial participants. Cancer. 131(1). e35586–e35586. 1 indexed citations

11.

Perez, Giselle K., et al.. (2023). Qualitative study of Oncology Clinicians’ Perceptions of Barriers to Offering Clinical Trials to Underserved Populations. Cancer Control. 30. 2915605877–2915605877. 5 indexed citations

12.

Munir, Muhammad Bilal, Muhammad Zia Khan, Taha Al‐Juhaishi, et al.. (2023). Association of atrial fibrillation and outcomes in patients undergoing bone marrow transplantation. EP Europace. 25(5). 3 indexed citations

13.

Perni, Subha, et al.. (2022). Financial Toxicity, Symptom Burden, Illness Perceptions, and Communication Confidence in Cancer Clinical Trial Participants. JCO Oncology Practice. 18(9). e1427–e1437. 15 indexed citations

14.

Fong, Zhi Ven, Ryan J. Hendrix, Carlos Fernández‐del Castillo, et al.. (2021). Patient and Caregiver Considerations and Priorities When Selecting Hospitals for Complex Cancer Care. Annals of Surgical Oncology. 28(8). 4183–4192. 13 indexed citations

15.

Fair, Douglas, Elyse R. Park, Ryan David Nipp, et al.. (2021). Material, behavioral, and psychological financial hardship among survivors of childhood cancer in the Childhood Cancer Survivor Study. Cancer. 127(17). 3214–3222. 18 indexed citations

16.

Best, Till D., Eric Roeland, Nora Horick, et al.. (2021). Muscle Loss Is Associated with Overall Survival in Patients with Metastatic Colorectal Cancer Independent of Tumor Mutational Status and Weight Loss. The Oncologist. 26(6). e963–e970. 18 indexed citations

17.

Johnson, P. Connor, Richard Newcomb, Hermioni L. Amonoo, et al.. (2021). End-of-Life Care for Older Adults with Aggressive Non-Hodgkin Lymphoma. Journal of Palliative Medicine. 25(5). 728–733. 3 indexed citations

18.

Deshields, Teresa L., Sharla Wells‐Di Gregorio, Stacy R. Flowers, et al.. (2021). Addressing distress management challenges: Recommendations from the consensus panel of the American Psychosocial Oncology Society and the Association of Oncology Social Work. CA A Cancer Journal for Clinicians. 71(5). 407–436. 50 indexed citations

19.

Petrillo, Laura A., Areej El‐Jawahri, Ryan David Nipp, et al.. (2020). Performance status and end‐of‐life care among adults with non–small cell lung cancer receiving immune checkpoint inhibitors. Cancer. 126(10). 2288–2295. 48 indexed citations

20.

Nipp, Ryan David, Aaron Philip Mitchell, Allyson M. Pishko, & Ara Metjian. (2014). Waldenström Macroglobulinemia in Hepatitis C: Case Report and Review of the Current Literature. Case Reports in Oncological Medicine. 2014. 1–7. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact